Cottrill R, Ekanayake A, Grove C, Peiris S, Corbett N, Ahmed B
J Alzheimers Dis Rep. 2025; 9:25424823251316134.
PMID: 40034519
PMC: 11864252.
DOI: 10.1177/25424823251316134.
Schaible P, Henschel J, Erny D
J Neuroinflammation. 2025; 22(1):60.
PMID: 40033338
PMC: 11877772.
DOI: 10.1186/s12974-025-03371-0.
Lu D, Ma X, Tao K, Lei H
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996827
PMC: 11853859.
DOI: 10.3390/cimb47020106.
Deng X, Gong X, Zhou D, Hong Z
Front Immunol. 2025; 16:1513599.
PMID: 39981228
PMC: 11839609.
DOI: 10.3389/fimmu.2025.1513599.
Polyak H, Galla Z, Rajda C, Monostori P, Klivenyi P, Vecsei L
Int J Mol Sci. 2025; 26(3).
PMID: 39940744
PMC: 11817772.
DOI: 10.3390/ijms26030976.
Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases.
Paul J, Azmal M, Haque A, Meem M, Talukder O, Ghosh A
World J Gastroenterol. 2025; 31(5):99913.
PMID: 39926224
PMC: 11718612.
DOI: 10.3748/wjg.v31.i5.99913.
Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism.
Fumagalli A, Castells-Nobau A, Trivedi D, Garre-Olmo J, Puig J, Ramos R
Gut Microbes. 2025; 17(1):2455506.
PMID: 39910065
PMC: 11810085.
DOI: 10.1080/19490976.2025.2455506.
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis.
Zhu W, Dykstra K, Zhang L, Xia Z
Curr Treat Options Neurol. 2025; 23(11).
PMID: 39877812
PMC: 11774507.
DOI: 10.1007/s11940-021-00693-1.
Alterations in Gut Microbiome-Host Relationships After Immune Perturbation in Patients With Multiple Sclerosis.
Gupta V, Janda G, Pump H, Lele N, Cruz I, Cohen I
Neurol Neuroimmunol Neuroinflamm. 2025; 12(2):e200355.
PMID: 39819054
PMC: 11741292.
DOI: 10.1212/NXI.0000000000200355.
Protection of Alzheimer's disease progression by a human-origin probiotics cocktail.
Prajapati S, Wang S, Mishra S, Jain S, Yadav H
Sci Rep. 2025; 15(1):1589.
PMID: 39794404
PMC: 11724051.
DOI: 10.1038/s41598-024-84780-8.
Gut microbiota mediated T cells regulation and autoimmune diseases.
Bhutta N, Xu X, Jian C, Wang Y, Liu Y, Sun J
Front Microbiol. 2025; 15:1477187.
PMID: 39749132
PMC: 11694513.
DOI: 10.3389/fmicb.2024.1477187.
Lysate of prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response.
Jiraskova Zakostelska Z, Kraus M, Coufal S, Prochazkova P, Slavickova Z, Thon T
Front Immunol. 2024; 15:1475126.
PMID: 39737164
PMC: 11682988.
DOI: 10.3389/fimmu.2024.1475126.
Predicting host health status through an integrated machine learning framework: insights from healthy gut microbiome aging trajectory.
Bao Z, Yang Z, Sun R, Chen G, Meng R, Wu W
Sci Rep. 2024; 14(1):31143.
PMID: 39732755
PMC: 11682237.
DOI: 10.1038/s41598-024-82418-3.
Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut-Brain Axis and Infection.
Boziki M, Theotokis P, Kesidou E, Nella M, Bakirtzis C, Karafoulidou E
Neurol Int. 2024; 16(6):1750-1778.
PMID: 39728753
PMC: 11677782.
DOI: 10.3390/neurolint16060127.
Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicry.
Ma X, Zhang J, Jiang Q, Li Y, Yang G
EBioMedicine. 2024; 111():105516.
PMID: 39724786
PMC: 11732510.
DOI: 10.1016/j.ebiom.2024.105516.
Multiple Sclerosis: Glial Cell Diversity in Time and Space.
Kooistra S, Schirmer L
Glia. 2024; 73(3):574-590.
PMID: 39719685
PMC: 11784844.
DOI: 10.1002/glia.24655.
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis.
Fan H, Shen R, Yan J, Bai Y, Fu Q, Shi X
Drug Des Devel Ther. 2024; 18:6145-6164.
PMID: 39717200
PMC: 11665440.
DOI: 10.2147/DDDT.S489454.
Gut microbiota and multiple sclerosis: a potential diagnostic and prognostic marker?.
Zoledziewska M, Lorefice L
Neurodegener Dis Manag. 2024; 14(6):189-192.
PMID: 39600266
PMC: 11703474.
DOI: 10.1080/17582024.2024.2435249.
Propionic Acid Impact on Multiple Sclerosis: Evidence and Challenges.
Lorefice L, Zoledziewska M
Nutrients. 2024; 16(22).
PMID: 39599673
PMC: 11597849.
DOI: 10.3390/nu16223887.
The Ocular Microbiome: Micro-Steps Towards Macro-Shift in Targeted Treatment? A Comprehensive Review.
Trojacka E, Izdebska J, Szaflik J, Przybek-Skrzypecka J
Microorganisms. 2024; 12(11).
PMID: 39597621
PMC: 11596073.
DOI: 10.3390/microorganisms12112232.